GEN Exclusives

More »

GEN News Highlights

More »
Apr 9, 2007

Nanoviricides and Walter Reed Team Up to Fight Dengue Fever

  • NanoViricides signed a CRADA with the Walter Reed Army Institute of Research (WRAIR). The joint R&D effort will focus on creating new treatments for dengue fever using NanoViricides’ virus-killing nanomedicine technology.

    "This collaboration will leverage Walter Reed’s extensive experience in dengue fever research with our unique nanoviricide™ technology platform for creating antiviral medications," says president, Anil Diwan.

    The company’s TheraCour technologies are used to develop nanotechnology-based targeted antiviral therapeutics.  



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Companion Animal Care

Do you think Americans spend too much on companion animal care?